DEUTSCHE BANK AG\ - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2016$11,000
-63.3%
4,787
+21.7%
0.00%
Q4 2015$30,000
+7.1%
3,934
-27.6%
0.00%
Q3 2015$28,000
-88.3%
5,432
-79.8%
0.00%
Q2 2015$240,000
-18.6%
26,845
-42.5%
0.00%
Q1 2015$295,000
+9733.3%
46,716
+7686.0%
0.00%
Q4 2014$3,0006000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2015
NameSharesValueWeighting ↓
Opaleye Management Inc. 565,000$4,334,0001.81%
Ghost Tree Capital, LLC 350,000$2,685,0001.10%
Avoro Capital Advisors LLC 340,300$2,610,0000.90%
PURA VIDA INVESTMENTS, LLC 217,900$1,671,0000.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,467,858$11,258,0000.55%
Broadfin Capital, LLC 890,748$6,832,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$10,090,0000.41%
Lombard Odier Asset Management (USA) Corp 348,641$2,674,0000.26%
TURNER INVESTMENTS LLC 122,000$936,0000.19%
Integre Asset Management, LLC 64,317$493,0000.12%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders